GCI Magazine

Segments Sponsored by

Email This Item!
Increase Text Size

Oriflame Announces Investment in Plant Stem Cells

Posted: October 22, 2013

In the search for sustainable anti-aging active ingredients, Oriflame announced significant investment in the cultivation of its own plant stem cell cultures. This innovative capability will allow Oriflame to develop powerful anti-aging ingredients that can boost and rejuvenate aging skin. The technique, at the leading edge of skin care science, is highly sustainable and 100% traceable. Plant stem cell technology also allows for the production of active ingredients that are completely safe and offer high purity, quality and effectiveness.

The sourcing of raw materials is of fundamental importance to Oriflame. As a company that has always respected environmental and ethical concerns, it is taking action to better manage natural resources and significantly lower its ecological footprint. Using plant stem cells carries a number of important benefits:

“Oriflame strives to innovate through science, explore new ingredients and seek new ways to bring nature’s goodness to our products in a sustainable manner. The use of plant stem cells reflects our core identity of fulfilling dreams in a natural, progressive and ethical way,” said Dr. Alain Mavon, skin research director at Oriflame. “It will give our consumers affordable skin care products containing highly effective, sustainable and safe active ingredients through breakthrough technology. Moreover, it demonstrates our emphasis on scientific endeavor and commitment to innovation that stands out in the direct selling industry.”

The announcement marks another significant innovation for Oriflame and is part of its enduring commitment to become a truly sustainable company. Oriflame’s work on plant stem cells began in December 2012 at its Skin Research Institute in Stockholm. In addition to installing a plant cell culture laboratory in-house, Oriflame has also entered into a collaborative partnership with Swedish company In vitro Plant-tech AB, which specializes in biomanufacturing cell cultures and explants from medicinal plants.